RETRACTED: Why are we vaccinating children against COVID-19?

Kostoff, Ronald N.; Calina, Daniela; Kanduc, Darja; Briggs, Michael B.; Vlachoyiannopoulos, Panayiotis G.; Svistunov, Andrey; Tsatsakis, Aristidis

doi:10.1016/j.toxrep.2021.08.010

Cited by 36 publications

(33 citation statements)

References 94 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6 However, the infection rate among children and adolescents is not negligible, and they can carry and spread the virus. 7 Furthermore, unvaccinated populations are supposedly suitable hosts for new variants. 8 Some recent data indicate that a few countries, for example, the USA are unlikely to reach the 70% target for herd immunity; however, vaccinating 22% of the American population, that is, the pediatric population, would boost community protection against COVID-19.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Parental coronavirus disease vaccine hesitancy for children in Bangladesh: a cross-sectional study

Ali¹,

Ahmed²,

Bonna

et al. 2022

F1000Res

View full text Add to dashboard Cite

Background: Coronavirus disease 2019 (COVID-19) requires mass immunization to control the symptoms and global spread of severe acute respiratory syndrome coronavirus 2. Data from developed countries reported a high prevalence of parental COVID-19 vaccine hesitancy. However, parental vaccine hesitancy data in countries with low and middle income are scarce. The goal of this study was to assess the prevalence of parental vaccine hesitancy and identify subgroups with higher odds of vaccine hesitancy. Methods: A cross-sectional study was conducted on parents of children aged <18 years from October 10, 2021, to October 31, 2021. Parents aged ≥18 years underwent face-to-face interviews in randomly selected places in Bangladesh using a vaccine hesitancy questionnaire. Predictors were identified using binary logistic regression analysis. Results: Data from 2633 eligible parents were analyzed. Overall, 42.8% reported COVID-19 vaccine hesitancy for their youngest child. The final model suggested that children's age, parent's age, religion, occupation, monthly household income, permanent address, living location, the status of tobacco use, adherence with the regular government vaccination programs (other than COVID-19), perception about COVID-19 vaccine efficacy among Bangladeshi children, self-vaccination intention, report about family members' illness or death from COVID-19, and perceived COVID-19 threat were the independent predictors of parental vaccine hesitancy. Conclusions: Vaccine hesitation varied based on sociodemographic characteristics, religion, behavior, and perceived COVID-19 threat. Therefore, interventions focused on addressing vaccine hesitancy among subgroups are warranted.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Parental coronavirus disease vaccine hesitancy for children in Bangladesh: a cross-sectional study

Ali¹,

Ahmed²,

Bonna

et al. 2022

F1000Res

View full text Add to dashboard Cite

show abstract

“…Unfortunately, such evidence is not easy to come by and will likely remain missing for some time, if not forever. It has, however, become evident that Covid-19 infections in children are often mild and that for children, the risk of developing a severe case of the disease is very low (Sinha et al 2020;Snape and Viner 2020;Zimmermann, Pittet, and Curtis 2021;Kostoff et al 2021).…”

Section: Discussionmentioning

confidence: 99%

Countries embracing maternal employment opened schools sooner after Covid-19 lockdowns

Nitsche¹,

Hudde²

2022

View full text Add to dashboard Cite

show abstract

“…The BNT162b2 vaccine in 12-to-15-year-old recipients has been reported favorable safety and highly effective against COVID-19 ( 9 ). However, due to the limited information from short-term trials and high post-inoculation severe adverse effects and deaths, there are still concerns that lag the vaccination rate on children/adolescents ( 10 ).…”

Section: Introductionmentioning

confidence: 99%

Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study

Hsieh

Chao

et al. 2022

Front. Nutr.

View full text Add to dashboard Cite

BackgroundSince late 2019, there has been a global COVID-19 pandemic. To preserve medical capacity and decrease adverse health effects, preventing the progression of COVID-19 to severe status is essential. Jing-Si Herbal Tea (JSHT), a novel traditional Chinese medicine formula was developed to treat COVID-19. This study examined the clinical efficacy and safety of JSHT in patients with mild-to-moderate COVID-19.MethodsIn this prospective cohort study, we enrolled 260 patients with mild-to-moderate COVID-19. The enrolled patients were divided into the JSHT (n = 117) and control (n = 143) groups. Both groups received standard management. The JSHT group was treated with JSHT as a complementary therapy.ResultsCompared with standard management alone, JSHT combined with standard management more effectively improved the reverse transcription–polymerase chain reaction cycle threshold value, C-reactive protein level, and Brixia score in the adult patients with mild-to-moderate COVID-19, especially in the male and older patients (those aged ≥60 years). The results revealed that the patients treated with JSHT combined with standard management had 51, 70, and 100% lower risks of intubation, Medisave Care Unit admission, and mortality compared with those receiving standard management only.ConclusionsJSHT combined with standard management more effectively reduced the SARS-CoV-2 viral load and systemic inflammation and alleviated lung infiltrates in the patients with mild-to-moderate COVID-19, especially in the male and older patients (those aged ≥60 years). JSHT combined with standard management may prevent critical status and mortality in patients with mild-to-moderate COVID-19. JSHT is a promising complementary therapy for patients with mild-to-moderate COVID-19.

show abstract

RETRACTED: Why are we vaccinating children against COVID-19?

Abstract: Graphical abstract

Cited by 36 publications

References 94 publications

Parental coronavirus disease vaccine hesitancy for children in Bangladesh: a cross-sectional study

Parental coronavirus disease vaccine hesitancy for children in Bangladesh: a cross-sectional study

Countries embracing maternal employment opened schools sooner after Covid-19 lockdowns

Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study

Contact Info

Product

Resources

About